drugset / Trial / NCT01641315
Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins
Non-randomizedParallel-groupSingle-blindPrevention
Summary
Reduced 4-dose intramuscular rabies vaccination schedule was announced by US-ACIP and WHO to be one of the post-exposure prophylaxis regimens. However, concurrent usage of this regimen with rabies immunoglobulin have never been studied in the aspect that the immunity level would above the protective level required by WHO (0.5 IU/ml) for at least a year period. This study would access this subject.
Timeline
- Start
- 2015-09
- Primary completion
- 2018-04
- Completion
- 2018-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabies vaccine | Vaccine | — | Intramuscular |
| Background | Equine Rabies Immunoglobulin | Protein / enzyme biologic | 40 iu/kg | — |